Article
FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia.
Clinical lymphoma, myeloma & leukemia - 1 Dec 2018
Perry Marielle, Bertoli Sarah, Rocher Clément, Hayette Sandrine, Ducastelle Sophie, Barraco Fiorenza, Labussière-Wallet Hélène, Salles Gilles, Recher Christian, Thomas Xavier, Paubelle Etienne
Abstract excerpt
BACKGROUND: Outcome of patients with mutation of the FLT3 tyrosine kinase domain (FLT3-TKD) in acute myeloid leukemia (AML) remains controversial. PATIENTS AND METHODS: Herein, we present a retrospective study of 126 newly diagnosed patients with AML performed in 2 French centers. RESULTS: FLT3-TKD mutations represented 12.7% of patients, whereas FLT3-internal tandem duplication (ITD) mutation was observed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
